Skip to content

D&A at other companies

Eli Lilly logo
Eli LillyLLY
$509M+9.9%
Cardinal Health logo
Cardinal HealthCAH
$248M+19.8%
Viatris logo
ViatrisVTRS
$676.1M+1.7%
The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
$1.62M-9.4%
Medline, Inc.
 logo
Medline, Inc. MDLN
$254M+2.8%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$39.09M-7.3%

Segments

By segment

See full
Oncology & Multispecialty$64M+77.8%
North American Pharmaceutical$36M+16.1%
Medical-Surgical Solutions$25M+4.2%
Prescription Technology Solutions$20M-4.8%

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%
Free cash flow$3.3B-56.3%

Valuation

See full
Market cap$89.39B-0.7%
Enterprise value$87.69B-11.0%
P/E18.8×-9.7×
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: McKesson’s 10-Q, filed February 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's D&A?
McKesson (MCK) reported D&A of $65M in Q4 2025.
How has McKesson's D&A changed year-over-year?
McKesson's D&A increased by 12.1% year-over-year, from $58M to $65M.
What is the long-term trend for McKesson's D&A?
Over 3 years (2022 to 2025), McKesson's D&A has grown at a -4.6% compound annual growth rate (CAGR), from $279M to $242M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.